Honorary Professor John Upham
Honorary Professor

John Upham

Email: 

Background

John Upham is a clinical scientist and physician with longstanding research interests in the immunological basis of asthma and chronic lung disease, the role of dendritic cells in allergy and virus infections of the lung, and the development of novel approaches to severe asthma treatment.

John is highly influential in his field, with > 195 publications, > 5,400 citations and an H index of 46. Since 2009, he has 112 publications (1st/senior author on 45%) with a Field-Weighted Citation Impact of 2.03. Moreover, 21.5% of publications are in the top 10% of most-cited publications worldwide (field-weighted). His publications have been cited in >20 different subject areas, demonstrating translation to fields other than Medicine. His research has international reach with citations in 80 countries (Scopus Dec 2018).

In the last 10 years, he has secured over $24 million in research funding. John has been awarded 8 NHMRC Project grants (4 as CIA in the last 5 years), 2 NHMRC CRE (“Closing the gap in Indigenous Lung Health” and “Severe Asthma”), and 1 NHMRC Development Grant. He currently holds NHMRC grants of $7.5 million, including $2.96 million as CIA. John was regularly an invited (9x), plenary (3x) and Chair (9x) at national and international conferences in the last 5 years. In recognition of his international standing and influence in the field, he was elected Fellow of the American Academy of Allergy, Asthma & Immunology (2004) and the Thoracic Society of Australia and New Zealand (2015).

Availability

Honorary Professor John Upham is:
Available for supervision
Media expert

Fields of research

Biomedical and Clinical Sciences Cardiovascular medicine and haematology Clinical sciences Immunology Respiratory diseases

Qualifications

  • Doctor of Philosophy, University of Western Australia

Research interests

  • Immune function and susceptibility to virus infections in asthma and COPD

  • Plasmacytoid dendritic cells

    Type I interferon production Immune regulation

  • Severe asthma: towards evidence-based assessment and management

  • Innate immunity and bacterial infections of the lungs

    Bronchiectasis and chronic suppurative lung disease in children Lung health in Indigenous children

  • Allergy and immune tolerance

Research impacts

John is currently the President (2021-22) of the Thoracic Society of Australia and Zealand and is a key member of the NHMRC funded Centre of Research Excellence (CRE) in Asthma Treatable Traits. He has played a leadership role in organising and co-chairing three recent national symposia on severe asthma to facilitate research collaboration, build research and clinical capacity, and improve models of care for severe asthma. He has been a member of multiple advisory boards to pharmaceutical companies, both international and national (AstraZeneca, GSK, Novartis, Nycomed, Boehringer-Ingelheim, Mundipharma, Menarini), and has provided advice to the Pharmaceutical Benefits Advisory Committee. His research has provided new treatment options for severe asthma, and guided the appropriate length of antibiotic treatment for Indigenous children with pneumonia, protracted bacterial bronchitis and bronchiectasis. John's research will inform best use of influenza vaccination in COPD, and guide the use of conjugate vaccines to improve immunity to Haemophilus in Indigenous children. He contributed to Clinical Practice Guidelines for the use of omalizumab and mepolizumab in Australia and he was part of the working group that prepared a web-based Severe Asthma Toolkit for the Severe Asthma CRE.

Search Professor John Upham’s works on UQ eSpace

381 works between 1983 and 2025
All (381) Journal Article (234) Book Chapter (5) Conference Publication (142)

21 - 40 of 381 works

2023

Journal Article

Maternal diet modulates the infant microbiome and intestinal Flt3L necessary for dendritic cell development and immunity to respiratory infection

Sikder, Md. Al Amin, Rashid, Ridwan B., Ahmed, Tufael, Sebina, Ismail, Howard, Daniel R., Ullah, Md. Ashik, Rahman, Muhammed Mahfuzur, Lynch, Jason P., Curren, Bodie, Werder, Rhiannon B., Simpson, Jennifer, Bissell, Alec, Morrison, Mark, Walpole, Carina, Radford, Kristen J., Kumar, Vinod, Woodruff, Trent M., Ying, Tan Hui, Ali, Ayesha, Kaiko, Gerard E., Upham, John W., Hoelzle, Robert D., Cuív, Páraic Ó., Holt, Patrick G., Dennis, Paul G. and Phipps, Simon (2023). Maternal diet modulates the infant microbiome and intestinal Flt3L necessary for dendritic cell development and immunity to respiratory infection. Immunity, 56 (5), 1098-1114.e10. doi: 10.1016/j.immuni.2023.03.002

Maternal diet modulates the infant microbiome and intestinal Flt3L necessary for dendritic cell development and immunity to respiratory infection

2023

Journal Article

Prime-boost, double-dose influenza vaccine immunity in COPD: a pilot observational study

Anderson, Gary P., Irving, Louis B., Jarnicki, Andrew, Kedzierska, Katherine, Koutsakos, Marios, Kent, Stephen, Hurt, Aeron C., Wheatley, Adam K., Nguyen, Thi H. O., Snape, Natale and Upham, John W. (2023). Prime-boost, double-dose influenza vaccine immunity in COPD: a pilot observational study. ERJ Open Research, 9 (2) 00641-2021, 1-9. doi: 10.1183/23120541.00641-2021

Prime-boost, double-dose influenza vaccine immunity in COPD: a pilot observational study

2023

Journal Article

Comorbidities modify the phenotype but not the treatment effectiveness to mepolizumab in severe eosinophilic asthma

Kritikos, Vicky, Harvey, Erin S., Stevens, Sean, Katelaris, Constance H., Langton, David, Rimmer, Janet, Farah, Claude S., Gillman, Andrew, Hew, Mark, Radhakrishna, Naghmeh, Thomas, Dennis, Gibson, Peter G., Baraket, Melissa, Bardin, Philip, Bowden, Jeffrey J., Bowler, Simon, Chien, Jimmy, Chung, Li Ping, Grainge, Christopher, Harkness, Nicholas, Harrington, Zinta, Jenkins, Christine, Katsoulotos, Gregory P., McDonald, Vanessa M., Lee, Joy, Peters, Matthew, Reddel, Helen K., Reynolds, Paul N., Sivakumaran, Pathmanathan ... Wark, Peter A. B. (2023). Comorbidities modify the phenotype but not the treatment effectiveness to mepolizumab in severe eosinophilic asthma. Journal of Allergy and Clinical Immunology: In Practice, 11 (3), 885-895.e13. doi: 10.1016/j.jaip.2022.12.004

Comorbidities modify the phenotype but not the treatment effectiveness to mepolizumab in severe eosinophilic asthma

2023

Conference Publication

Demographic and clinical characteristics of patients with severe asthma in the Asian pacific region: Data from the International Severe Asthma Registry (ISAR)

Price, David, Rhee, Chin Kook, Tran, Trung N., Katial, Rohit, Martin, Neil, Peters, Matthew, Denton, Eve, Upham, John W., Bardin, Philip, Cochrane, Belinda, Middleton, Peter G., Reynolds, Paul, Perng, Diahn-Warng, Wang, Hao-Chien, Sheu, Chau-Chyun and Tsai, Ming-Ju (2023). Demographic and clinical characteristics of patients with severe asthma in the Asian pacific region: Data from the International Severe Asthma Registry (ISAR). HOBOKEN: WILEY.

Demographic and clinical characteristics of patients with severe asthma in the Asian pacific region: Data from the International Severe Asthma Registry (ISAR)

2023

Journal Article

Excess visceral adipose tissue is associated with poorer lung function and increased airway inflammation in adults with asthma

Valkenborghs, S.R., Wood, L.G., Callister, R., Upham, J.W., Grainge, C.L., Anderson, S., Williams, L.M., McLoughlin, R.F., Williams, E.J. and Scott, H.A. (2023). Excess visceral adipose tissue is associated with poorer lung function and increased airway inflammation in adults with asthma. Proceedings of the Nutrition Society, 82 (OCE2) E192. doi: 10.1017/s002966512300201x

Excess visceral adipose tissue is associated with poorer lung function and increased airway inflammation in adults with asthma

2022

Journal Article

Comparing the effect of acute moderate and vigorous exercise on inflammation in adults with asthma: a randomized controlled trial

Scott, Hayley A., Wood, Lisa G., Williams, Evan J., Weaver, Natasha and Upham, John W. (2022). Comparing the effect of acute moderate and vigorous exercise on inflammation in adults with asthma: a randomized controlled trial. Annals of the American Thoracic Society, 19 (11), 1848-1855. doi: 10.1513/AnnalsATS.202109-1053OC

Comparing the effect of acute moderate and vigorous exercise on inflammation in adults with asthma: a randomized controlled trial

2022

Journal Article

The impact of meal dietary inflammatory index on exercise-induced changes in airway inflammation in adults with asthma

McDiarmid, Katrina P., Wood, Lisa G., Upham, John W., MacDonald-Wicks, Lesley K., Shivappa, Nitin, Hebert, James R. and Scott, Hayley A. (2022). The impact of meal dietary inflammatory index on exercise-induced changes in airway inflammation in adults with asthma. Nutrients, 14 (20) 4392, 1-11. doi: 10.3390/nu14204392

The impact of meal dietary inflammatory index on exercise-induced changes in airway inflammation in adults with asthma

2022

Conference Publication

Right heart strain assessment on CTPA following acute pulmonary embolism: interobserver variability between radiologists and thoracic physicians

Samaranayake, C., Craigie, M., Bell, P., Mccabe, C., Upham, J., Coucher, J. and Keir, G. (2022). Right heart strain assessment on CTPA following acute pulmonary embolism: interobserver variability between radiologists and thoracic physicians. 2022 ERS International Congress, Barcelona, Spain, 4-6 September 2022. Sheffield, United Kingdom: European Respiratory Society. doi: 10.1183/13993003.congress-2022.1823

Right heart strain assessment on CTPA following acute pulmonary embolism: interobserver variability between radiologists and thoracic physicians

2022

Conference Publication

Understanding how azithromycin reduces asthma exacerbations and the underlying mechanisms of macrolides

Jurak, L., Yang, I., Hill, M., Simpson, J. and Upham, J. (2022). Understanding how azithromycin reduces asthma exacerbations and the underlying mechanisms of macrolides. ERS International Congress 2022, Barcelona, Spain, 4-6 September 2022. Sheffield, United Kingdom: European Respiratory Society. doi: 10.1183/13993003.congress-2022.4372

Understanding how azithromycin reduces asthma exacerbations and the underlying mechanisms of macrolides

2022

Journal Article

Home Administration of Biologics for Severe Asthma—A Good Option for Some but Not All

Upham, John W. (2022). Home Administration of Biologics for Severe Asthma—A Good Option for Some but Not All. Journal of Allergy and Clinical Immunology: In Practice, 10 (9), 2324-2325. doi: 10.1016/j.jaip.2022.06.007

Home Administration of Biologics for Severe Asthma—A Good Option for Some but Not All

2022

Journal Article

Right heart strain assessment on CTPA following acute pulmonary embolism: interobserver variability between expert radiologists and physicians

Samaranayake, Chinthaka B., Craigie, Michelle, Kempny, Aleksander, Bell, Peter T., McCann, Andrew, Wahi, Sudhir, Upham, John W., McCabe, Colm, Coucher, John and Keir, Gregory (2022). Right heart strain assessment on CTPA following acute pulmonary embolism: interobserver variability between expert radiologists and physicians. Respiratory Medicine, 200 106928, 1-7. doi: 10.1016/j.rmed.2022.106928

Right heart strain assessment on CTPA following acute pulmonary embolism: interobserver variability between expert radiologists and physicians

2022

Journal Article

Characterisation of the Australian adult population living with asthma: severe - exacerbation frequency, long-term OCS use and adverse effects

Hancock, Kerry L, Bosnic-Anticevich, Sinthia, Blakey, John D, Hew, Mark, Chung, Li Ping, Cvetkovski, Biljana, Claxton, Scott, Del Fante, Peter, Denton, Eve, Doan, Joe, Ranasinghe, Kanchanamala, Morgan, Lucy, Sharma, Anita, Smith, Peter K, Stewart, Deb, Thompson, Philip J, Wiseman, Russell, Upham, John W, Yan, Kwok Y, Carter, Victoria, Dhillon, Kiranjeet, Heraud, Florian, Le, Thao, Vella, Rebecca and Price, David (2022). Characterisation of the Australian adult population living with asthma: severe - exacerbation frequency, long-term OCS use and adverse effects. Pragmatic and Observational Research, Volume 13, 43-58. doi: 10.2147/por.s360044

Characterisation of the Australian adult population living with asthma: severe - exacerbation frequency, long-term OCS use and adverse effects

2022

Journal Article

‘Breathing Fire’: impact of prolonged bushfire smoke exposure in people with severe asthma

Beyene, Tesfalidet, Harvey, Erin S., Van Buskirk, Joseph, McDonald, Vanessa M., Jensen, Megan E., Horvat, Jay C., Morgan, Geoffrey G., Zosky, Graeme R., Jegasothy, Edward, Hanigan, Ivan, Murphy, Vanessa E., Holliday, Elizabeth G., Vertigan, Anne E., Peters, Matthew, Farah, Claude S., Jenkins, Christine R., Katelaris, Constance H., Harrington, John, Langton, David, Bardin, Philip, Katsoulotos, Gregory P., Upham, John W., Chien, Jimmy, Bowden, Jeffrey J., Rimmer, Janet, Bell, Rose and Gibson, Peter G. (2022). ‘Breathing Fire’: impact of prolonged bushfire smoke exposure in people with severe asthma. International Journal of Environmental Research and Public Health, 19 (12) 7419, 1-15. doi: 10.3390/ijerph19127419

‘Breathing Fire’: impact of prolonged bushfire smoke exposure in people with severe asthma

2022

Journal Article

Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2019: the Influenza Complications Alert Network (FluCAN)

Cheng, Allen C., Dwyer, Dominic E., Holmes, Mark, Irving, Louis, Simpson, Graham, Senenayake, Sanjaya, Korman, Tony, Friedman, N Deborah, Cooley, Louise, Wark, Peter, Holwell, Anna, Bowler, Simon, Upham, John, Fatovich, Daniel M., Waterer, Grant, Blyth, Christopher C., Crawford, Nigel, Buttery, Jim, Marshall, Helen S., Clark, Julia E., Francis, Joshua, Macartney, Kristine, Kotsimbos, Tom and Kelly, Paul (2022). Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2019: the Influenza Complications Alert Network (FluCAN). Communicable Diseases Intelligence, 46. doi: 10.33321/cdi.2022.46.14

Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2019: the Influenza Complications Alert Network (FluCAN)

2022

Journal Article

Extended versus standard antibiotic course duration in children <5 years of age hospitalized with community-acquired pneumonia in high-risk settings: four-week outcomes of a multicenter, double-blind, parallel, superiority randomized controlled trial

McCallum, Gabrielle B., Fong, Siew M., Grimwood, Keith, Nathan, Anna M., Byrnes, Catherine A., Ooi, Mong H., Nachiappan, Nachal, Saari, Noorazlina, Morris, Peter S., Yeo, Tsin W., Ware, Robert S., Elogius, Blueren W., Oguoma, Victor M., Yerkovich, Stephanie T., de Bruyne, Jessie, Lawrence, Katrina A., Lee, Bilawara, Upham, John W., Torzillo, Paul J. and Chang, Anne B. (2022). Extended versus standard antibiotic course duration in children <5 years of age hospitalized with community-acquired pneumonia in high-risk settings: four-week outcomes of a multicenter, double-blind, parallel, superiority randomized controlled trial. The Pediatric Infectious Disease Journal, 41 (7), 549-555. doi: 10.1097/INF.0000000000003558

Extended versus standard antibiotic course duration in children <5 years of age hospitalized with community-acquired pneumonia in high-risk settings: four-week outcomes of a multicenter, double-blind, parallel, superiority randomized controlled trial

2022

Journal Article

Surveillance for severe influenza and COVID-19 in patients admitted to sentinel Australian hospitals in 2020: the Influenza Complications Alert Network (FluCAN)

Begum, Husna, Dwyer, Dominic E., Holmes, Mark, Irving, Louis, Simpson, Graham, Senenayake, Sanjaya, Korman, Tony, Friedman, N Deborah, Cooley, Louise, Wark, Peter, Bowler, Simon, Kok, Jen, Upham, John, Fatovich, Daniel M., Waterer, Grant, Macartney, Kristine, Blyth, Christopher C., Crawford, Nigel, Buttery, Jim, Marshall, Helen S., Clark, Julia E., Francis, Joshua R., Kotsimbos, Tom, Kelly, Paul and Cheng, Allen (2022). Surveillance for severe influenza and COVID-19 in patients admitted to sentinel Australian hospitals in 2020: the Influenza Complications Alert Network (FluCAN). Communicable Diseases Intelligence, 46. doi: 10.33321/cdi.2022.46.13

Surveillance for severe influenza and COVID-19 in patients admitted to sentinel Australian hospitals in 2020: the Influenza Complications Alert Network (FluCAN)

2022

Journal Article

Philip Morris International buys inhaler company Vectura to expand reach in electronic cigarettes

Carson‐Chahhoud, Kristin V., Thompson, Bruce R., Upham, John W. and Thoracic Society of Australia and New Zealand (2022). Philip Morris International buys inhaler company Vectura to expand reach in electronic cigarettes. Respirology, 27 (5), 328-330. doi: 10.1111/resp.14244

Philip Morris International buys inhaler company Vectura to expand reach in electronic cigarettes

2022

Journal Article

Reply to “‘Nothing about us without us’ — What matters to patients with severe asthma?”

Upham, John W., Le Lievre, Chantal, Jackson, David J., Masoli, Matthew, Wechsler, Michael E. and Price, David B. (2022). Reply to “‘Nothing about us without us’ — What matters to patients with severe asthma?”. Journal of Allergy and Clinical Immunology: In Practice, 10 (3), 891-891. doi: 10.1016/j.jaip.2021.12.036

Reply to “‘Nothing about us without us’ — What matters to patients with severe asthma?”

2022

Journal Article

Direct oral anticoagulants for cancer associated venous thromboembolisms: a systematic review and network meta-analysis: DOACs for VTE in Cancer

Samaranayake, Chinthaka B., Anderson, James, McCabe, Colm, Zahir, Syeda Farah, Upham, John and Keir, Gregory (2022). Direct oral anticoagulants for cancer associated venous thromboembolisms: a systematic review and network meta-analysis: DOACs for VTE in Cancer. Internal Medicine Journal, 52 (2) 15049, 272-281. doi: 10.1111/imj.15049

Direct oral anticoagulants for cancer associated venous thromboembolisms: a systematic review and network meta-analysis: DOACs for VTE in Cancer

2022

Journal Article

Vaccine strain affects seroconversion after influenza vaccination in COPD patients and healthy older people

Snape, Natale, Anderson, Gary P., Irving, Louis B., Jarnicki, Andrew G., Hurt, Aeron C., Collins, Tina, Xi, Yang and Upham, John W. (2022). Vaccine strain affects seroconversion after influenza vaccination in COPD patients and healthy older people. npj Vaccines, 7 (1) 8, 8. doi: 10.1038/s41541-021-00422-4

Vaccine strain affects seroconversion after influenza vaccination in COPD patients and healthy older people

Current funding

  • 2023 - 2028
    Minimising Oral Corticosteroid use in Asthma using Treatable Traits (2021 MRFF Chronic Respiratory Conditions grant Administering Institution University of Newcastle)
    University of Newcastle
    Open grant
  • 2020 - 2025
    Centre of Research Excellence in Asthma Treatable Traits (CREATT) (administered by University of Newcastle)
    University of Newcastle
    Open grant

Past funding

  • 2021 - 2024
    Diagnostic utility of tests of latent tuberculosis in immune compromised contacts exposed to multi-drug resistant tuberculosis (2021 Metro South SERTA Novice Researcher Grant administered by MSHHS)
    Metro South Hospital and Health Service
    Open grant
  • 2020 - 2021
    Reducing acute severe respiratory events in health care workers during the Covid-19 pandemic with OM85
    NHMRC MRFF Coronavirus Research Response
    Open grant
  • 2018 - 2022
    Understanding how azithromycin prevents exacerbations in severe asthma
    NHMRC Project Grant
    Open grant
  • 2017 - 2020
    Anti-viral immune dysfunction in severe asthma varies across inflammatory phenotypes
    NHMRC Project Grant
    Open grant
  • 2017 - 2020
    Multicentre randomised controlled trial on duration of antibiotics for children with chronic wet cough - (Children's Hospital Foundation grant administered by QUT)
    Queensland University of Technology
    Open grant
  • 2016
    Abberant immune responses to viruses in severe asthma: what role does IL-33 play? (Seed Grant awarded by NHMRC CCRE in Severe Asthma APP1078579 administered by the University of Newcastle)
    University of Newcastle
    Open grant
  • 2016 - 2022
    A multi-centre double-blind RCT on community-acquired pneumonia in Indigenous children and a developing country (NHMRC Project Grant administered by Menzies School of Health Research)
    Menzies School of Health Research
    Open grant
  • 2015 - 2019
    Improving asthma through lifestyle interventions: how much exercise is best?
    Asthma Australia Incorporated
    Open grant
  • 2015 - 2019
    Using influenza vaccination to understand and improve anti-viral immunity in COPD
    NHMRC Project Grant
    Open grant
  • 2014 - 2020
    National Clinical Centre of Research Excellence in Severe Asthma (NHMRC CRE administered by the University of Newcastle)
    University of Newcastle
    Open grant
  • 2013 - 2015
    Anti-viral immunity in asthma: a detailed assessment of TLR7 function and the regulation of interferon a/B synthesis
    NHMRC Project Grant
    Open grant
  • 2013 - 2016
    Protracted bacterial bronchitis: long term outcomes, systemic and airway predictors of recurrence (NHMRC Project Grant administered by Menzies)
    The Menzies Foundation
    Open grant
  • 2012 - 2017
    Centre of Research Excellence in Lung Health of Aboriginal and Torres Strait Islander Children (NHMRC CRE administered by Menzies School of Health Research)
    Menzies School of Health Research
    Open grant
  • 2012 - 2015
    Defective toll-like receptor 7 signalling in plasmacytoid dendritic cells underlies the inception of virus-associated asthma
    NHMRC Project Grant
    Open grant
  • 2012
    Influenza vaccination and asthma
    Asthma Foundation of Queensland
    Open grant
  • 2012
    Microbial immunity in a large population of adult asthmatics with suboptimal disease control
    PA Research Foundation Private Practice Trust Fund Research Support Grants
    Open grant
  • 2012 - 2013
    The airway epithelium in paediatric respiratory diseases
    UWA-UQ Bilateral Research Collaboration Award
    Open grant
  • 2011
    Allergic sensitization to grass pollens in patients with allergic rhinitis and asthma in subtropical regions of Australia (Year 2)
    Asthma Foundation of Queensland
    Open grant
  • 2011
    Understanding immune responses to influenza vaccination in people with asthma
    Asthma Foundation of Queensland
    Open grant
  • 2010 - 2011
    Development of the major Bahia grass pollen allergen, Pas n 1, as an immunodiagnostic test for subtropical grass pollen allergy
    UQ FirstLink Scheme
    Open grant
  • 2010 - 2012
    Protracted bacterial bronchitis in children: what is the natural history and role of innate immunity dysfunction?
    Financial Markets Foundation for Children
    Open grant
  • 2010
    Allergic sensitization to grass pollens in patients with allergic rhinitis and asthma in subtropical regions of Australia
    Asthma Foundation of Queensland
    Open grant
  • 2010
    Allergy to subtropical grass pollens in Australia: IgE cross-reactivity between subtropical and temperate grass pollens
    Open grant
  • 2009
    Antiviral innate immunity in asthma: why are some people with asthma susceptible to virus infections?
    Asthma Foundation of Queensland
    Open grant
  • 2009
    Prevention of allergic asthma through induction of tolerance in allergen-sensitised T cells
    Asthma Foundation of Queensland
    Open grant
  • 2009 - 2015
    The AMAZES Study: Asthma and Macrolides: the AZithromycin Efficacy and Safety study (NHMRC Project Grant administered by University of Newcastle)
    University of Newcastle
    Open grant
  • 2008 - 2010
    Anti-viral immunity in asthma and chronic obstructive pulmonary disease (COPD)
    Princess Alexandra Hospital R&D Foundation
    Open grant
  • 2008
    Antiviral innate immunity in asthma: why are some people with asthma susceptible to virus infections?
    Asthma Foundation of Queensland
    Open grant
  • 2008 - 2012
    NHMRC Practitioner Fellowship
    NHMRC Practitioner Fellowship
    Open grant
  • 2008 - 2009
    Protracted bronchitis in children: what is the natural history and role of innate immunity dysfunction?
    Royal Children's Hospital Foundation
    Open grant
  • 2007
    NHMRC Practitioner Fellowship
    NHMRC Practitioner Fellowship
    Open grant
  • 2007 - 2011
    Developmental aspects of respiratory inflammation, allergy and asthma (UWA_lead institution)
    University of Western Australia
    Open grant

Availability

Honorary Professor John Upham is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Available projects

  • Immune dysregulation in asthma and host defence against respiratory viruses

    Our program of translational research is focussed on the study of immune function and dysfunction in asthma, and host defence against respiratory viruses, especially human rhinoviruses. We are interested in the mechanisms leading to excessive airway inflammation in asthma, and why people with asthma are unusually susceptible to asthma attacks during respiratory viral infections. Our aim is to discover new therapeutic targets in severe asthma.

    Research Projects

    • The function of key immune cells such as antigen presenting cells and NK cells
    • The role of polarizing cytokines such as IL-33, IL-25 and TSLP in altering host defence against viruses.
    • How macrolide antibiotics alter immune function

Supervision history

Current supervision

Completed supervision

Enquiries

Contact Honorary Professor John Upham directly for media enquiries about:

  • Allergies
  • Asthma
  • Chronic obstructive pulmonary disease
  • Dendritic cells
  • Immunity
  • Lung infections
  • Lungs - virus infections
  • Virus infections of the lung

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au